D

Dicerna Pharmaceuticals

Lexington, United States Founded 2007
Nanomedicine Drug Delivery Gene Therapy Delivery Lipid Nanoparticles mRNA Delivery Nanobiosensors

About

RNAi therapeutics using GalNAc delivery (acquired by Novo Nordisk)

Company Details

Type
commercial
Employees
300+
Funding
$3.3B (acquired)

Key Products

  • GalXC Platform
  • RNAi Therapeutics
Visit Website

Related Companies

N

Nanosys

Milpitas, United States

N

Nanosphere (Luminex)

Northbrook, United States

N

Nanocomp Technologies

Merrimack, United States

N

NanoString Technologies

Seattle, United States